How should I evaluate and manage a filling defect in the right pulmonary artery?

Evaluation and Management of Right Pulmonary Artery Filling Defect

A filling defect in the right pulmonary artery requires immediate CT pulmonary angiography (CTPA) review to confirm true pulmonary embolism versus artifact, followed by risk stratification and anticoagulation if PE is confirmed. 1, 2

Initial Diagnostic Confirmation

Request radiologist review or second opinion before initiating treatment, as modern CTPA has high false-positive rates, particularly for subsegmental defects, and misdiagnosis leads to unnecessary anticoagulation with 1-3% annual major bleeding risk. 2

Distinguish True PE from Artifacts

True pulmonary embolism demonstrates: 1

• Filling defect visible on multiple consecutive slices and in multiple planes
• Distinct, sharp borders with contrast material 1, 3
• "Rim sign" (contrast surrounding central defect) or "railway track sign" (parallel lines of contrast) 1
• Acute angles with vessel wall if positioned eccentrically 3

Common technical artifacts that mimic PE include: 1, 2

• Transient interruption of contrast from deep inspiration (unopacified IVC blood mixing with opacified SVC blood)
• Flow artifacts from Valsalva maneuver during breath-hold (right-to-left shunting causing poor pulmonary artery enhancement)
• Streak artifacts from high-concentration contrast in superior vena cava 4
• Breathing motion artifacts creating pseudo-hypoattenuating areas 4

Optimize Image Quality if Initial Study is Suboptimal

If image quality is inadequate: 1

• Coach patient to maintain shallow breath hold (not deep inspiration)
• Reduce scan delay to 5 seconds if central venous catheter present
• Use low-concentration contrast (120-200 mg iodine/ml) at high flow (4-5 ml/s) to reduce streak artifacts in right pulmonary artery 4

Risk Stratification Based on PE Location and Extent

For Isolated Subsegmental PE

Perform bilateral lower extremity venous ultrasound to exclude proximal DVT, as DVT presence mandates anticoagulation regardless of PE size. 2

If no DVT is found: 2

• Low recurrence risk patients (provoked PE, no cancer, no prior VTE): Consider clinical surveillance over anticoagulation
• High recurrence risk patients (unprovoked PE, active cancer, prior VTE): Anticoagulation preferred over surveillance

For Segmental or More Proximal PE

Assess right ventricular function via echocardiography or CT to stratify risk and determine need for intensive monitoring versus early discharge. 5, 2

Echocardiographic findings suggesting RV dysfunction include: 5

• RV dilation with basal RV/LV ratio >1.0
• TAPSE <16 mm
• McConnell sign (hypo/akinetic mid and basal RV free wall with normal/hyperkinetic apex)
• Flattened interventricular septum
• Distended IVC with diminished inspiratory collapsibility

Anticoagulation Management

Initiation

Start anticoagulation immediately while diagnostic workup proceeds, unless active bleeding or absolute contraindications exist. 2

Prefer direct oral anticoagulants (DOACs) over warfarin for ease of use and similar efficacy. 2

For high-risk PE with hemodynamic instability: 6

• Administer unfractionated heparin with weight-adjusted bolus without delay
• Consider systemic thrombolytic therapy as first-line treatment unless contraindicated
• Provide hemodynamic support with norepinephrine and/or dobutamine

Duration

Minimum 3 months anticoagulation for all confirmed PE. 6, 2

After 3 months, reassess: 2

• Provoked PE (e.g., recent surgery, trauma): Discontinue anticoagulation
• Unprovoked/idiopathic PE: Continue 6-12 months minimum, reassess for extended therapy
• Active cancer: Extended anticoagulation with LMWH or DOAC per cancer-associated thrombosis guidelines

Differential Diagnosis Beyond Thromboembolism

Consider alternative diagnoses when clinical presentation is inconsistent with PE: 7, 8

• Pulmonary artery sarcoma (eccentric mass contiguous with vessel wall, irregular vessel diameter) 4
• Tumor embolism (known malignancy, multiple filling defects)
• In situ thrombosis (pulmonary hypertension, chronic changes)
• External compression (aortic dissection, mediastinal mass) 9
• Pulmonary artery stenosis (congenital, chronic changes)

Critical Pitfalls to Avoid

• Do not assume all filling defects are PE—particularly isolated subsegmental defects require careful confirmation 2
• Do not delay anticoagulation while awaiting confirmatory testing in patients with high clinical probability and adequate image quality 6
• Do not anticoagulate without excluding proximal DVT first when considering surveillance for isolated subsegmental PE 2
• Do not ignore RV assessment—it determines prognosis and monitoring intensity 5, 2
• Review cine-mode viewing and multiplanar reformations to distinguish true filling defects from flow artifacts 4